Literature DB >> 10068108

Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study.

S Faouzi1, B Le Bail, V Neaud, L Boussarie, J Saric, P Bioulac-Sage, C Balabaud, J Rosenbaum.   

Abstract

BACKGROUND/AIMS: Marked changes in extracellular matrix occur in the stroma of hepatocellular carcinoma, as compared to normal or cirrhotic liver. The cell types responsible for extracellular matrix synthesis within hepatocellular carcinoma have not been clearly identified.
METHODS: In vivo collagen synthesis was studied by in situ hybridization and immunohistochemistry for types I, IV, V and VI collagen, together with immunolabeling of alpha-smooth muscle actin, a myofibroblast marker, and CD34, an endothelial cell marker. In vitro, extracellular matrix deposition by cultured myofibroblasts was studied by reticulin staining, immunocytochemistry and RNase protection.
RESULTS: All collagens studied were expressed in the stroma of the tumor, with a higher level of type VI and IV collagens than of type I and V. The majority of the cells expressing collagen transcripts in human hepatocellular carcinoma stroma were alpha-actin positive and CD 34 negative. In vitro experiments demonstrated that the hepatocellular carcinoma cell lines HepG2, HuH7 and Hep3B markedly increased extracellular matrix deposition by human liver myofibroblasts. This increase was mediated by a soluble mediator present in tumor cell conditioned medium. It was not explained by an increase in mRNA levels of extracellular matrix components, nor by a decrease in the secretion of matrix-degrading proteinases by myofibroblasts.
CONCLUSIONS: Myofibroblasts are the main source of collagens in the stroma of hepatocellular carcinoma. Our data also indicate that tumoral hepatocytes increase extracellular matrix deposition by cultured myofibroblasts, probably by post-transcriptional mechanisms. The generation of hepatocellular carcinoma stroma by myofibroblasts could thus be under control of tumoral cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10068108     DOI: 10.1016/s0168-8278(99)80074-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  32 in total

1.  Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum.

Authors:  Yunhong Xia; Rongxin Chen; Zhenji Song; Shenglong Ye; Ruixia Sun; Qiong Xue; Zhe Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

Review 2.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

3.  Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2.

Authors:  Obul R Bandapalli; Stephan Macher-Goeppinger; Peter Schirmacher; Karsten Brand
Journal:  Clin Exp Metastasis       Date:  2012-02-24       Impact factor: 5.150

Review 4.  Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?

Authors:  Derek C Radisky; Paraic A Kenny; Mina J Bissell
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

Review 5.  Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis.

Authors:  Ana C Martins Cavaco; Sara Dâmaso; Sandra Casimiro; Luís Costa
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

6.  Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.

Authors:  H Reynaert; K Rombouts; A Vandermonde; D Urbain; U Kumar; P Bioulac-Sage; M Pinzani; J Rosenbaum; A Geerts
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 7.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

Review 8.  Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications.

Authors:  Xiangyu Kong; Lei Li; Zhaoshen Li; Keping Xie
Journal:  Cytokine Growth Factor Rev       Date:  2012-07-01       Impact factor: 7.638

Review 9.  Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction.

Authors:  Clifford J Whatcott; Haiyong Han; Daniel D Von Hoff
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

10.  Human corneal fibrosis: an in vitro model.

Authors:  Dimitris Karamichos; Xiaoqing Q Guo; Audrey E K Hutcheon; James D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-29       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.